Minova Life Science

Minova life sciences - Pharmaceutical company

Fexocon-120

Get Freedom from Seasonal Allergic Rhinitis

 

COMPOSITION

Fexofenadine HCL-120 mg/180 mg

INDICATION

  • Seasonal Allergic Rhinitis
  • Chronic Idiopathic Urticaria

Fexocon-120

  • Nonsedating, long-acting H1 receptor antagonist that provides fast and effective relief from Seasonal allergic Rhinitis
  •  Reduces nasal inflammation by modulating the release of proinflammatory mediators and adhesion molecules from human nasal epithelial cells
  •  Relieves the symptoms of sneezing, rhinorrhoea, itchy nose, palate or throat, and itchy, watery, red eyes in patients with allergic rhinitis
  • More effective than loratadine in relieving eye symptoms and nasal congestion
  • Effective in reducing pruritus severity, number of wheals, and interference with sleep and normal daily activities in patients with chronic urticaria
 

                                                                     Breath On

Explore other products

Scroll to Top